Elizabeth D. Hood
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery 10
- Pharmaceutical Science top 5%
- Immunology and Allergy top 10%
- Biomedical Engineering top 10%
- Nanoplatforms for cancer theranostics 4
- Hematology top 10%
- Blood Coagulation and Thrombosis Mechanisms 3
-
- Complement system in diseases 8
-
- Monoclonal and Polyclonal Antibodies Research 8
-
- Erythrocyte Function and Pathophysiology 3
-
- RNA Interference and Gene Delivery 3
-
- Advanced Nanomaterials in Catalysis 3
- Co-authors
- Vladimir R. MuzykantovColin F. GreinederVladimir V. ShuvaevMelissa D. HowardMichael ChornyRobert J. LevyBlaine J. ZernJacob W. Myerson
- Journals
- Journal of Controlled Release (6 papers)Bioconjugate Chemistry (5 papers)Advanced Materials (3 papers)
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
Elizabeth D. Hood
44 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 128
- Biomaterials 439
- Pharmaceutical Science 76
- Immunology and Allergy 75
- Biomedical Engineering 455
- Hematology 93
Countries citing papers authored by Elizabeth D. Hood
This map shows the geographic impact of Elizabeth D. Hood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth D. Hood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth D. Hood more than expected).
Fields of papers citing papers by Elizabeth D. Hood
This network shows the impact of papers produced by Elizabeth D. Hood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth D. Hood. The network helps show where Elizabeth D. Hood may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elizabeth D. Hood, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 19 | |
| 3 | 2023 | 10 | |
| 4 | 2021 | 72 | |
| 5 | 2019 | 46 | |
| 6 | 2018 | 16 | |
| 7 | 2017 | 29 | |
| 8 | 2017 | 11 | |
| 9 | 2017 | 29 | |
| 10 | 2015 | 24 | |
| 11 | 2014 | 81 | |
| 12 | 2014 | 88 | |
| 13 | 2013 | 42 | |
| 14 | 2012 | 64 | |
| 15 | 2011 | 65 | |
| 16 | 2011 | 4 | |
| 17 | 2009 | 11 | |
| 18 | 2008 | 2 | |
| 19 | 2007 | 23 | |
| 20 | 2005 | 3 |
About Elizabeth D. Hood
Elizabeth D. Hood is a scholar working on Applied Microbiology and Biotechnology, Biomaterials and Hematology, having authored 46 papers that have together received 1.6k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (10 papers), Complement system in diseases (8 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Nanoplatforms for cancer theranostics (4 papers), Erythrocyte Function and Pathophysiology (3 papers), RNA Interference and Gene Delivery (3 papers), Advanced Nanomaterials in Catalysis (3 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). The work is most often cited by research in Biomaterials (439 citations), Pharmaceutical Science (76 citations) and Immunology and Allergy (75 citations). Elizabeth D. Hood has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Vladimir R. Muzykantov, Colin F. Greineder, Vladimir V. Shuvaev, Melissa D. Howard, Michael Chorny, Robert J. Levy, Blaine J. Zern, Jacob W. Myerson, Patrick M. Glassman and Raisa Y. Kiseleva. Their work appears in journals such as Journal of Controlled Release, Bioconjugate Chemistry, Advanced Materials, Advanced Drug Delivery Reviews and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.